Tiptuximab
Latest Information Update: 19 Sep 2023
At a glance
- Originator Medical Guidance Systems
- Class Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Intracellular signalling peptide and protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 19 Sep 2023 Discontinued - Preclinical for Cancer in USA (Parenteral) (Medical Guidance Systems website, September 2023)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Cancer in USA (Parenteral)
- 12 Aug 2016 Preclinical trials in Cancer in USA (Parenteral)